Literature DB >> 20526198

Extracranial injuries are important in determining mortality of neurotrauma.

Kwok M Ho1, Maxine Burrell, Sudhakar Rao.   

Abstract

OBJECTIVE: This study aimed to assess the significance of extracranial injuries, as measured by Injury Severity Score, on 6-mo and 9-yr mortality of neurotrauma.
DESIGN: Retrospective linked data cohort study.
SETTING: A major neurotrauma center in Western Australia. PATIENTS: Six hundred eighty-three adult neurotrauma patients.
MEASUREMENTS AND MAIN RESULTS: Data were first used to validate the largest published international neurotrauma "extended" mortality prognostic model, in which extracranial injuries are considered significant if the patient has hypoxemia or hypotension on admission. Logistic and Cox regression, incorporating bootstrap techniques to adjust for overfitting, were used to assess the significance of Injury Severity Score in determining 6-mo and 9-yr mortality, respectively. Among a total of 683 patients admitted between 1994 and 2002, 636 (93.1%) had extracranial injuries. The international neurotrauma "extended" mortality prognostic model was poorly calibrated and underestimated the observed mortality (slope and intercept of the calibration curve were 2.14 and 0.35, respectively) when applied to our patients. Incorporating Injury Severity Score into the model improved its calibration. Injury Severity Score accounted for 11% of the variability and was the third most important factor after Marshall computed tomographic grading (17.8%) and pupil reactivity (14.5%) in determining 6-mo mortality. There was a notable increase in mortality between 6-mo (19.2%) and 24-mo follow-up (25.8%). Injury Severity Score remained important and accounted for 9.2% of the variability in determining 9-yr mortality after the injury.
CONCLUSIONS: Hypotension and hypoxemia on admission were inadequate markers of extracranial injuries; incorporating more comprehensive extracranial injury assessment by the Injury Severity Score to the standard neurologic prognostic factors improved the accuracy of predictions on mortality after neurotrauma.

Entities:  

Mesh:

Year:  2010        PMID: 20526198     DOI: 10.1097/CCM.0b013e3181e2ccd8

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  6 in total

1.  Frequency and impact of intensive care unit complications on moderate-severe traumatic brain injury: early results of the Outcome Prognostication in Traumatic Brain Injury (OPTIMISM) Study.

Authors:  Susanne Muehlschlegel; Raphael Carandang; Cynthia Ouillette; Wiley Hall; Fred Anderson; Robert Goldberg
Journal:  Neurocrit Care       Date:  2013-06       Impact factor: 3.210

2.  Comparison of CT and MRI in diagnosis of cerebrospinal leak induced by multiple fractures of skull base.

Authors:  Xuhui Wang; Minhui Xu; Hong Liang; Lunshan Xu
Journal:  Radiol Oncol       Date:  2011-03-15       Impact factor: 2.991

3.  Chest injuries associated with head injury.

Authors:  Wilfred Chukwuemeka Mezue; Chika A Ndubuisi; Uwadiegwu A Erechukwu; Samuel C Ohaegbulam
Journal:  Niger J Surg       Date:  2012-01

4.  Detailed assessment of benefits and risks of retrievable inferior vena cava filters on patients with complicated injuries: the da Vinci multicentre randomised controlled trial study protocol.

Authors:  Kwok M Ho; Sudhakar Rao; Stephen Honeybul; Rene Zellweger; Bradley Wibrow; Jeffrey Lipman; Anthony Holley; Alan Kop; Elizabeth Geelhoed; Tomas Corcoran
Journal:  BMJ Open       Date:  2017-07-12       Impact factor: 2.692

5.  A comparison of prognostic significance of strong ion gap (SIG) with other acid-base markers in the critically ill: a cohort study.

Authors:  Kwok M Ho; Norris S H Lan; Teresa A Williams; Yusra Harahsheh; Andrew R Chapman; Geoffrey J Dobb; Sheldon Magder
Journal:  J Intensive Care       Date:  2016-06-29

6.  Outcomes after Traumatic Brain Injury with Concomitant Severe Extracranial Injuries.

Authors:  Tomoo Watanabe; Yasuyuki Kawai; Asami Iwamura; Naoki Maegawa; Hidetada Fukushima; Kazuo Okuchi
Journal:  Neurol Med Chir (Tokyo)       Date:  2018-08-11       Impact factor: 1.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.